Pathway to discovery in rare disease
Sanofi researchers are investigating a metabolic hub that plays a key role in three classes of rare disease
The Fight against COVID-19
As the pandemic continues, Sanofi is at the forefront of vaccine development, while carrying on the daily business of making and delivering medicines for patients
Supporting People with Cancer during COVID-19
Despite the challenges caused by COVID-19, Sanofi continues to support the patient communities it serves—including the cancer community
Third Quarter Results 2020
Sanofi’s financial results will be published on October 29, providing a look at its business performance and the execution of its strategy
-
Press releases2020-10-26MMMM DD YYYYDupixent® (dupilumab) late-breaking pivotal data showing significant improvement in eosinophilic esophagitis signs and symptoms presented for the first time at scientific meetings